1. Home
  2. NMTC vs BEAT Comparison

NMTC vs BEAT Comparison

Compare NMTC & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeuroOne Medical Technologies Corporation

NMTC

NeuroOne Medical Technologies Corporation

HOLD

Current Price

$1.85

Market Cap

29.2M

Sector

Health Care

ML Signal

HOLD

Logo Heartbeam Inc.

BEAT

Heartbeam Inc.

HOLD

Current Price

$0.61

Market Cap

27.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMTC
BEAT
Founded
2009
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
29.2M
27.7M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
NMTC
BEAT
Price
$1.85
$0.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$11.90
$5.63
AVG Volume (30 Days)
48.2K
496.2K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
80.43
15.07
EPS
N/A
N/A
Revenue
$9,097,692.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$31.90
$315.97
P/E Ratio
N/A
N/A
Revenue Growth
163.47
N/A
52 Week Low
$0.55
$0.48
52 Week High
$5.40
$4.00

Technical Indicators

Market Signals
Indicator
NMTC
BEAT
Relative Strength Index (RSI) 43.40 56.11
Support Level $0.66 $0.61
Resistance Level $1.98 $0.70
Average True Range (ATR) 0.21 0.04
MACD 0.05 0.02
Stochastic Oscillator 77.14 88.94

Price Performance

Historical Comparison
NMTC
BEAT

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.

Share on Social Networks: